AT THE FOREFRONT OF
CRISPR THERAPEUTICS DEVELOPMENT
Directly addressing the inherent limitations of current CRISPR methodologies, our technology seeks to unlock previously unattainable avenues in the development of CRISPR based therapeutics.
"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
PROF. GEORGE CHURCH, CRISPR PIONEER
FIND OUT MORE.I
7171 Frederick Banting
Saint-Laurent H4S 1Z9